Abnormal accumulation of TDP-43 into cytoplasmic or nuclear inclusions with accompanying nuclear clearance, a common pathology initially identified in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), has also been found in Alzheimer’ disease (AD). TDP-43 serves as a splicing repressor of nonconserved cryptic exons and that such function is compromised in brains of ALS and FTD patients, suggesting that nuclear clearance of TDP-43 underlies its inability to repress cryptic exons. However, whether TDP-43 cytoplasmic aggregates are a prerequisite for the incorporation of cryptic exons is not known. Here, we assessed hippocampal tissues from 34 human postmortem brains including cases with confirmed diagnosis of AD neuropathologic changes along with age-matched controls. We found that cryptic exon incorporation occurred in all AD cases exhibiting TDP-43 pathology. Furthermore, incorporation of cryptic exons was observed in the hippocampus when TDP-43 inclusions was restricted only to the amygdala, the earliest stage of TDP-43 progression. Importantly, cryptic exon incorporation could be detected in AD brains lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. These data supports the notion that the functional consequence of nuclear depletion of TDP-43 as determined by cryptic exon incorporation likely occurs as an early event of TDP-43 proteinopathy and may have greater contribution to the pathogenesis of AD than currently appreciated. Early detection and effective repression of cryptic exons in AD patients may offer important diagnostic and therapeutic implications for this devastating illness of the elderly.
Bibliographical noteFunding Information:
We thank G. Rudow for assistance in collecting brain tissues. This research was supported in part by McKnight endowment fund for neuroscience (P.C.W and L.C.), the Johns Hopkins Alzheimer’s Disease Research Center pilot grant (L.C.; NIH P50AG05146), the Packard Center for ALS (L.C. and P.C.W.), the JHU Neuropathology Pelda fund (P.C.W.) and the NIH Grant (P.C.W.; R01 NS095969).
© 2017, Springer-Verlag Berlin Heidelberg.
- Alzheimer’s disease
- Cryptic exon
- Hippocampal sclerosis
- TDP-43 proteinopathy